The US FDA approved Epidiolex® (cannabidiol, or CBD) for certain seizure syndromes in June, 2018, and in November, 2018, the DEA rescheduled it as a Schedule V controlled substance (the least restrictive). This will greatly facilitate clinical use and clinical trials of CBD in the U.S. Note that there is little evidence at this point […]
A fascinating publication from the University of Nottingham describes a non-invasive method that may reduce tics. The idea is that rhythmic input to a brain region can entrain that region to fire in synchrony with the input, and some rhythmic firing patterns seem to inhibit movement. The stimulation was delivered by generating a small electrical […]
We just published results showing that brain structure, measured by MRI when we first met children with recent onset of tics, helped predict how much improvement there would be in a clinical rating scale for tics when the children returned at the 1-year anniversary of their first tic. Read more about it either here, written […]
Since the Tourette Association of America’s National Awareness 5K was cancelled, they have created an event that everyone can participate in and fundraise for from across the nation called Miles for Tourette! This new virtual event takes place throughout Awareness Month (May 15 – June 15) and they have scheduled weekly fitness classes along with physical fitness […]
We are currently working to adapt the New Tics study so that study visits can occur online, for optimal safety for all due to the COVID-19 pandemic. As further information about online study visits becomes available, we’ll add updates here: https://tics.wustl.edu/participate/new-tics-study/ Stay safe everyone!
Twenty-seven people responded to our survey asking people what content they wanted for our Tic Talk 2020 meeting (May 2, here at Wash. U.). Thank you! Most respondents (81%) were family members of someone with tics. And … the envelope, please! Here are the main results: Topics you are interested in: Tics at school, working […]
Teva Pharmaceuticals recently announced that in a couple of studies, deutetrabenazine did not prove statistically superior to placebo for treatment of Tourette syndrome in youth.* This honestly comes as a big surprise to me (and of course to the sponsor). Although without controlled trial evidence, its parent drug tetrabenazine had been used for tics for […]
The Tourette Association of America’s PANDAS/PANS Workgroup has issued a public statement about PANDAS. It succinctly summarizes the current state of evidence about this controversial diagnosis. A recommended read for anyone interested.
Below is a brief summary of the results from the first 21 people to take the survey. If you haven’t already responded, we’d love your input to help us design Tic Talk 2020 by taking this short 5-question survey: https://www.surveymonkey.com/r/8XT6Z7K Topics you are interested in: Tics and school: 76% How psychological factors or situations influence tics: […]
Tic Talk 2020 is on! Saturday, May 2, 2020, at Wash. U. School of Medicine. We want to hear from you about what topics we should cover. Please take this short 5-question survey: https://www.surveymonkey.com/r/8XT6Z7K Thank you!